Can the Nottingham Hip Fracture Score Predict Total Hip Replacement Versus Hemiarthroplasty Candidates?

诺丁汉髋关节骨折评分能否预测全髋关节置换术与半髋关节置换术的适用人群?

阅读:1

Abstract

BACKGROUND: The choice between total hip replacement (THR) and hemiarthroplasty in displaced intracapsular hip fractures remains debated. Procedure selection can be difficult given the current evidence. Using the Nottingham Hip Fracture Score (NHFS), we aimed to introduce objectivity into decision-making. METHODS: This is a retrospective single-centre review (2019-2023) of 1210 patients undergoing THR (n=228) or hemiarthroplasty (n=982). NHFS was calculated for all patients in this time period. Outcomes included one‑year mortality and discharge destination, with subgroup analysis of NHFS 4-6 and patients aged >80 with NHFS 4-6. Statistical analysis was completed using IBM SPSS Statistics for Windows, Version 28.0 (IBM Corp., Armonk, New York, United States).  Results: Hemiarthroplasty patients were older (82.2 vs. 74.6 years) and had higher mean NHFS (6.0 vs. 3.5) and higher one‑year mortality (36.2% vs. 3.5%). In the overall cohort, THR patients were more likely to be discharged home (65% vs. 39%), while hemiarthroplasty patients were more often discharged to institutional care. In the NHFS 4-6 subgroup, THR patients had lower mortality (3.4% vs. 29.6%; p<0.05) and more frequent home discharge (77.7% vs. 43.9%). In patients over 80 with NHFS 4-6, THR was associated with lower one-year mortality (4.2% vs. 13.8%) and a higher likelihood of independent living at home (75% vs. 60.9%) compared with hemiarthroplasty, although differences did not reach statistical significance. CONCLUSION: Hemiarthroplasty patients are older and have higher mortality. Within NHFS 4-6 and in some circumstances, THR was associated with lower mortality and more favourable discharge outcomes. NHFS may complement the National Institute for Health and Care Excellence (NICE) guidance in identifying candidates most likely to benefit from THR vs. hip hemiarthroplasty.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。